Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1259608-21-3

Post Buying Request

1259608-21-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1259608-21-3 Usage

Description

(2R)-2-Amino-2-cyclobutylethan-1-ol HCl is a chemical compound that is used in the pharmaceutical industry as a potential medicine. It is an amino alcohol that contains a cyclobutyl group and has a hydrochloride salt form. The presence of the hydrochloride salt form suggests that it may have good solubility in water, which could be advantageous for drug formulation and delivery.

Uses

Used in Pharmaceutical Industry:
(2R)-2-Amino-2-cyclobutylethan-1-ol HCl is used as a potential medicine for the treatment of various medical conditions. Its specific uses and properties are still under investigation, but its unique structure and good solubility in water may contribute to its potential applications in drug development and formulation. Further research is required to fully understand the potential uses and effects of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1259608-21-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,9,6,0 and 8 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1259608-21:
(9*1)+(8*2)+(7*5)+(6*9)+(5*6)+(4*0)+(3*8)+(2*2)+(1*1)=173
173 % 10 = 3
So 1259608-21-3 is a valid CAS Registry Number.

1259608-21-3Upstream product

1259608-21-3Downstream Products

1259608-21-3Relevant articles and documents

Immunomodulator

-

Paragraph 0254; 0369-0370; 0372, (2021/05/22)

The invention discloses an immunomodulator, and particularly relates to a compound for inhibiting IL-17A and application of the compound serving as the immunomodulator in preparation of drugs. The invention discloses application of a compound shown in a formula I or a stereoisomer thereof in preparation of medicines for inhibiting IL-17A, and provides a new choice for clinically screening and/or preparing medicines for treating diseases related to IL-17A activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1259608-21-3